document.write("
"); document.write("
Wille,\ K.*\ ; Dumke,\ M.*\ ; Wilsdorf,\ N.*\ ; Sadjadian,\ P.*\ ; Schneider,\ A.*\ ; Jender-Bartling,\ S.*\ ; Kolatzki,\ V.*\ ; Horstmann,\ A.*\ ; Meixner,\ R.\ ; Jiménez-Muñoz,\ M.\ ; Fuchs,\ C.\ ; Tischler,\ H.J.*\ ; Griesshammer,\ M.*
"); document.write("
Venetoclax combined with FLAG-IDA in refractory or relapsed acute myeloid leukemia.
"); document.write("
Eur. J. Haematol., DOI: 10.1111/ejh.14302 (2024)
"); document.write("
"); document.write("
"); document.write("
Wille,\ K.*\ ; Huenerbein,\ K.*\ ; Jagenberg,\ E.*\ ; Sadjadian,\ P.*\ ; Becker,\ T.*\ ; Kolatzki,\ V.*\ ; Meixner,\ R.\ ; Marchi,\ H.\ ; Fuchs,\ C.\ ; Griesshammer,\ M.*
"); document.write("
Bleeding complications in \bcr-abl\-negative myeloproliferative neoplasms (MPN): A retrospective single-center study of 829 MPN patients.
"); document.write("
Eur. J. Haematol., DOI: 10.1111/ejh.13721 (2021)
"); document.write("
"); document.write("
"); document.write("
Hentschel,\ N.*\ ; Krusch,\ M.*\ ; Kiener,\ P.A.*\ ; Kolb,\ H.-J.\ ; Salih,\ H.R.*\ ; Schmetzer,\ H.M.
"); document.write("
Serum levels of sCD137 (4-1BB) ligand are prognostic factors for progression in acute myeloid leukemia but not in non-Hodgkin\'s lymphoma.
"); document.write("
Eur. J. Haematol. 77, 91-101 (2006)
"); document.write("
"); document.write("
"); document.write("
Spiekermann,\ K.\ ; Biethahn,\ S.*\ ; Wilde,\ S.*\ ; Hiddemann,\ W.\ ; Alves,\ F.*
"); document.write("
Constitutive activation of STAT transcription factors in acute myelogenous leukemia.
"); document.write("
Eur. J. Haematol. 67, 63-71 (2001)
"); document.write("
"); document.write("
"); document.write("
Nüßler,\ V.\ ; Sauer,\ H.J.\ ; Pelka-Fleischer,\ R.\ ; Holzel Wilmanns,\ D.W.
"); document.write("
Clinical, biochemical and cytokinetic parameters for distinguishing smouldering and rapidly proliferating variants of acute leukaemia.
"); document.write("
Eur. J. Haematol. 45, 19-25 (1990)
"); document.write("
");